Please use this identifier to cite or link to this item:
Title: Is the radial artery associated with improved survival in older patients undergoing coronary artery bypass grafting? An analysis of a multicentre experience
Epworth Authors: Hayward, Philip
Fuller, John
Other Authors: Shi, William
Tatoulis, James
Rosalion, Alexander
Newcomb, Andrew
Buxton, Brian
Keywords: Arterial Grafting
Cardiac Surgery
Coronary Artery Bypass Grafting
Coronary Artery Disease
Coronary Revascularization
Radial Artery
Victorian Heart Centre, Epworth Hospital, Melbourne, VIC, Australia
Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Feb-2015
Publisher: Elsevier
Citation: Eur J Cardiothorac Surg. 2015 Feb 10
Abstract: OBJECTIVES: Studies suggest that the radial artery (RA) may exhibit superior patency compared with the saphenous vein (SV). It is unclear whether older patients undergoing coronary artery bypass grafting (CABG) derive any survival benefit from the use of RAs. We sought to evaluate this using a multicentre database. METHODS: From 1995 to 2010, 6059 patients with three-vessel coronary artery disease underwent primary isolated CABG at 8 centres. A study cohort of 4006 patients was formed with 3220 (80%) receiving at least 1 RA to supplement a single in situ internal thoracic artery (RA group) while 786 (20%) received only veins to supplement a single ITA (SV group). In the RA group, bilateral RAs were used in 1418 (44%) cases, while total arterial revascularization was achieved in 1859 (58%). RAs were mostly grafted to the left circumflex and right coronary territories. Survival data were obtained using the National Death Index and propensity-score matching was used for risk adjustment. Separate propensity-score analyses were conducted for the 2149 patients (1645 RA, 504 SV) who were 70 years or older. RESULTS: Patients receiving RAs were younger (mean age in years RA: 68 ± 9.7 vs SV: 71 ± 7.9, P < 0.001) and less likely to have cerebrovascular disease, obstructive airways disease, myocardial infarction within 7 days and left-main coronary disease. At 30 days, RA patients experienced reduced unadjusted mortality (49 of 3220, 1.5% vs 25 of 786, 3.2%, P = 0.004). At 15 years, the RA group showed superior unadjusted survival (51 ± 1.1 vs 35 ± 1.9%, P < 0.001). After propensity-score matching of 507 patient pairs, there was comparable 30-day mortality between groups (RA: 9, 1.8 vs SV: 14, 2.8%, P = 0.41). However, at 15 years, the RA group still showed superior survival (42 ± 2.6 vs 35 ± 2.5%, P = 0.008). Among those 70 years and older (327 matched pairs), despite similar 30-day mortality (RA: 6, 1.8% vs SV: 10, 3.1%, P = 0.42), RA patients again exhibited improved survival (35 ± 3.3 vs 22 ± 2.8%, P = 0.004) at 15 years. CONCLUSIONS: This multicentre analysis suggests that the use of an RA is associated with a survival benefit in older patients undergoing CABG.
DOI: doi: 10.1093/ejcts/ezv012
PubMed URL:
ISSN: 1987-2014
Journal Title: European Journal of Cardio-Thoracic Surgery
Type: Journal Article
Affiliated Organisations: Department of Cardiac Surgery, Austin Hospital, Melbourne, VIC, Australia
Department of Surgery, University of Melbourne, Melbourne, VIC, Australia
Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Department of Surgery, University of Melbourne, Melbourne, VIC, Australia
Department of Cardiothoracic Surgery, St Vincent's Hospital, Melbourne, VIC, Australia.
Type of Clinical Study or Trial: Cohort Study
Appears in Collections:Cardiac Sciences

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.